A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

L Scott; O Soepenberg; Jaap Verweij; Maja de Jonge; AST Planting; D McGovern; P Principe; R Obach; C Twelves

doi:10.1093/annonc/mdl439

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

L Scott, O Soepenberg, Jaap Verweij, Maja de Jonge, AST Planting, D McGovern, P Principe, R Obach, C Twelves

Medical Oncology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	569-575
Number of pages	7
Journal	Annals of Oncology
Volume	18
Issue number	3
DOIs	https://doi.org/10.1093/annonc/mdl439
Publication status	Published - 2007

Research programs

EMC MM-03-86-08

Access to Document

10.1093/annonc/mdl439

http://hdl.handle.net/1765/36501

Cite this

Scott, L., Soepenberg, O., Verweij, J., de Jonge, M., Planting, AST., McGovern, D., Principe, P., Obach, R., & Twelves, C. (2007). A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours. Annals of Oncology, 18(3), 569-575. https://doi.org/10.1093/annonc/mdl439

@article{0e8d9834219d429bbedf557b82e69454,

title = "A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours",

author = "L Scott and O Soepenberg and Jaap Verweij and \{de Jonge\}, Maja and AST Planting and D McGovern and P Principe and R Obach and C Twelves",

year = "2007",

doi = "10.1093/annonc/mdl439",

language = "Undefined/Unknown",

volume = "18",

pages = "569--575",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "3",

}

Scott, L, Soepenberg, O, Verweij, J, de Jonge, M, Planting, AST, McGovern, D, Principe, P, Obach, R & Twelves, C 2007, 'A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours', Annals of Oncology, vol. 18, no. 3, pp. 569-575. https://doi.org/10.1093/annonc/mdl439

A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours. / Scott, L; Soepenberg, O; Verweij, Jaap et al.
In: Annals of Oncology, Vol. 18, No. 3, 2007, p. 569-575.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A multicentre phase I and pharmacokinetic study of BN80915 (diflomotecan) administered daily as a 20-min intravenous infusion for 5 days every 3 weeks to patients with advanced solid tumours

AU - Scott, L

AU - Soepenberg, O

AU - Verweij, Jaap

AU - de Jonge, Maja

AU - Planting, AST

AU - McGovern, D

AU - Principe, P

AU - Obach, R

AU - Twelves, C

PY - 2007

Y1 - 2007

U2 - 10.1093/annonc/mdl439

DO - 10.1093/annonc/mdl439

M3 - Article

SN - 0923-7534

VL - 18

SP - 569

EP - 575

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -